未登录

N

Nagendra N. Mishra

University of California San Diego

H指数:28

被引数:3,770

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phage-Encoded Virulence Factor, Gp05, Alters Membrane Phospholipids and Reduces Antimicrobial Susceptibility in Methicillin-Resistant Staphylococcus aureus

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2024-12-310

PRE

Brilacidin, a novel antifungal agent against Cryptococcus neoformans

IF4.7

2024-07-172

OAAI

Membrane Phenotypic, Metabolic and Genotypic Adaptations of Streptococcus oralis Strains Destined to Rapidly Develop Stable, High-Level Daptomycin Resistance during Daptomycin Exposures

ANTIBIOTICS-BASEL

IF4.6

2023-06-210

OA

Combinations of Daptomycin plus Ceftriaxone, but Not Ascending Daptomycin Dose-Regimens, Are Effective in Experimental Endocarditis Caused by Streptococcus mitis-oralis Strains: Target Tissue Clearances and Prevention of Emergence of Daptomycin-Resistance

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2023-04-182

OA

Activity of the Lactate Dehydrogenase Inhibitor Oxamic Acid against the Fermentative Bacterium Streptococcus mitis/oralis: Bactericidal Effects and Prevention of Daptomycin Resistance In Vitro and in an Ex Vivo Model

ANTIBIOTICS-BASEL

IF4.6

2022-10-133

OA

Synergy Mechanisms of Daptomycin-Fosfomycin Combinations in Daptomycin-Susceptible and -Resistant Methicillin-Resistant Staphylococcus aureus: In Vitro, Ex Vivo, and In Vivo Metrics

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2022-01-1814

OA

β-Lactam-Induced Cell Envelope Adaptations, Not Solely Enhanced Daptomycin Binding, Underlie Daptomycin-β-Lactam Synergy in Methicillin-Resistant Staphylococcus aureus

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2021-07-166

OA

Cell Membrane Adaptations Mediate β-Lactam-Induced Resensitization of Daptomycin-Resistant (DAP-R) Staphylococcus aureus In Vitro

IF4.2

2021-05-117

OAAI

Impact of Bicarbonate on PBP2a Production, Maturation, and Functionality in Methicillin-Resistant Staphylococcus aureus

碳酸氢盐对耐甲氧西林金黄色葡萄球菌中PBP2a产生，成熟和功能的影响

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2021-04-1916

OAAI

Mechanistic Fingerprinting Reveals Kinetic Signatures of Resistance to Daptomycin and Host Defense Peptides in Streptococcus mitis-oralis

ANTIBIOTICS-BASEL

IF4.6

2021-04-082

OAAI

Prolonged Exposure to β-Lactam Antibiotics Reestablishes Susceptibility of Daptomycin-Nonsusceptible Staphylococcus aureus to Daptomycin

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2020-08-2014

OA

Strain-Specific Adaptations ofStreptococcus mitis-oralisto Serial In Vitro Passage in Daptomycin (DAP): Genotypic and Phenotypic Characteristics

ANTIBIOTICS-BASEL

IF4.6

2020-08-155

OAAI

Metabolic changes associated with adaptive resistance to daptomycin inStreptococcus mitis-oralis

BMC MICROBIOLOGY

IF4.2

2020-06-1510

OAAI

Proteomic and Membrane Lipid Correlates of Re-duced Host Defense Peptide Susceptibility in a snoD Mutant of Staphylococcus aureus

ANTIBIOTICS-BASEL

IF4.6

2019-09-284

OAAI

Daptomycin Dose-Ranging Evaluation with Single-Dose versus Multidose Ceftriaxone Combinations against Streptococcus mitis/oralis in an Ex Vivo Simulated Endocarditis Vegetation Model

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2019-06-0113

OAAI

Metabolic interventions for the prevention and treatment of daptomycin non-susceptibility in Staphylococcus aureus

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2019-05-1012

PREAI

Comparative Efficacies of Linezolid vs. Tedizolid in an Experimental Murine Model of Vancomycin-Resistant Enterococcal (VRE) Bacteremia

FRONTIERS IN MEDICINE

IF3

2019-02-208

OAAI

Mutations in cdsA and pgsA Correlate with Daptomycin Resistance in Streptococcus mitis and S. oralis

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2019-02-0125

OAAI

Membrane trafficking of the bacterial adhesin GspB and the accessory Sec transport machinery

细菌粘附素GspB和辅助Sec运输机械的膜运输

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2019-02-014

OAAI

Gain-of-Function Mutations in the Phospholipid Flippase MprF Confer Specific Daptomycin Resistance

IF4.7

2018-12-2174

OAAI